Aziyo Biologics (ELUT) Stock Statistics & Valuation Metrics

Aziyo Biologics has a market cap or net worth of $93.27M. The enterprise value is $120.52M.

Aziyo Biologics has 38,081,936 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aziyo Biologics’s return on equity (ROE) is 1.17 and return on invested capital (ROIC) is -84894.31%.

The current PE Ratio of Aziyo Biologics is ―. Aziyo Biologics’s PEG ratio is ―.

In the last 12 months, Aziyo Biologics had revenue of 24.38M and earned -53.95M in profits. Earnings per share was -1.86.

In the last 12 months, operating cash flow was -32.79M and capital expenditures -473.00K, giving a free cash flow of -33.27M billion.

Aziyo Biologics pays an annual dividend of ―, resulting in a dividend yield of ―

Aziyo Biologics upcoming earnings date is Nov 17, 2025, After Close (Confirmed).

Aziyo Biologics as a current ratio of 0.69, with Debt / Equity ratio of -67.49%

In the past 12 months, Aziyo Biologics has paid 7.00K in taxes.

Aziyo Biologics EV to EBITDA ratio is -2.62, with an EV/FCF ratio of -5.16.

Aziyo Biologics has $8.50M in cash and marketable securities with $28.24M in debt, giving a net cash position of $19.74M billion.

Gross margin is 44.67%, with operating margin of -146.26%, and net profit margin of -221.33%.

The average price target for Aziyo Biologics is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy